Roivant Sciences

Roivant is a biopharmaceutical holding company headquartered in New York. The company owns subsidiaries that develop and manufacture drugs in the areas of immunology, dermatology, hematology, neurology, oncology, and infectious and respiratory diseases. Roivant also conducts research of gene, RNA and silicon therapeutics, protein degraders, and provides Big Data and AI services for the healthcare industry. For drug discovery, Roivant employs in silico drug design and machine learning modeling. In China, the company runs a cellular therapeutics programme and already has 3 drugs for treatment of different diseases in the pipeline. In total, Roivant's subsidiaries have 17 drugs in the pipeline, with development stages ranging from preclinical to phase 3 clinical trials.